生物技术进展 ›› 2022, Vol. 12 ›› Issue (6): 922-928.DOI: 10.19586/j.2095-2341.2022.0129

• 研究论文 • 上一篇    下一篇

免疫系统人源化小鼠模型构建技术探讨

范蓓1(), 王园园2(), 赵云霞2, 江魁3, 王斌3   

  1. 1.华兰生物工程股份有限公司,河南 新乡 453000
    2.河南晟明生物技术研究院有限公司,河南 新乡 453600
    3.华兰基因工程有限公司,河南 新乡 453600
  • 收稿日期:2022-07-11 接受日期:2022-08-18 出版日期:2022-11-25 发布日期:2022-11-30
  • 通讯作者: 王园园
  • 作者简介:范蓓 E-mail: lansedaiwei06@163.com

Discussion on the Construction Technology of Mouse Model with Mumanized Immune

Bei FAN1(), Yuanyuan WANG2(), Yunxia ZHAO2, Kui JIANG3, Bin WANG3   

  1. 1.Hualan Biological Engineering Co. ,Ltd,Henan Xinxiang 453000,China
    2.Henan Shengming Biotechnology Research Institute Co. ,Ltd,Henan Xinxiang 453600,China
    3.Hualan Gene Engineering Co. ,Ltd,Henan Xinxiang 453600,China
  • Received:2022-07-11 Accepted:2022-08-18 Online:2022-11-25 Published:2022-11-30
  • Contact: Yuanyuan WANG

摘要:

探讨免疫系统人源化小鼠模型构建技术的方法和技巧,能够提高免疫系统人源化小鼠模型构建的成功率,并为后续的肿瘤免疫治疗药物研发提供临床前动物模型。利用不同移植数量和供体的HuPB-MNC细胞尾静脉注射重度免疫缺陷小鼠NCG,建立免疫系统人源化小鼠模型。每周观察2次,并记录小鼠体重及死亡情况;实验第7、14、21、28和35天眼眶静脉丛试血,流式细胞术监测NCG小鼠外周血中人CD45+ T细胞的重建水平。NCG小鼠外周血中人CD45+ T细胞水平随注射后时间逐渐升高,约在3~4周达到25%以上。研究结果表明,免疫系统人源化小鼠模型构建应该从构建方法、免疫缺陷小鼠品系、性别和饲养、免疫细胞的供体和数量及细胞状态等各个方面进行考虑,通过采用多种供体克服差异性,优化肿瘤模型和免疫细胞供体联合接种方案最大化利用窗口期等策略提高模型构建成功率及应用转化率,进一步完善实验室免疫系统人源化小鼠模型构建方法,以期为肿瘤免疫疗法提供更有利的药物研发工具。

关键词: NCG小鼠, 免疫系统人源化, Hu-PBL模型, 临床前动物模型

Abstract:

To improve the construction success rate of the mouse model with humanized immune system and provide preclinical animal model for further research on tumor immunotherapy drugs, the methods and techniques of the mouse model with humanized immune system construction were explored. The mouse model with humanized immune system was established by injecting HuPB-MNC cells with different numbers and five donors into tail vein of severely immunodeficient mice NCG. The body weight and mortality were recorded twice a week; on the 7th, 14th, 21st, 28th, 35th day of the experiment, blood were collected from orbital venous plexus, and the human CD45+ T cells reconstruction level in NCG mice peripheral blood was detected by flow cytometry. The level of CD45+ T cells in peripheral blood of NCG mice increased gradually with the time after injection, and reached more than 25% at about 3~4 weeks. The results showed that, the construction of the mouse model with humanized immune system should consider the construction method, the strain, sex and feeding of immunodeficient mice, the donor, number and cell state of immune cells. Strategies such as overcoming the differences by adopting multiple donors, and maximizing the window period by optimizing tumor model and immune cell donor combined inoculation plan, which can improve the success rate of model construction and application conversion rate, further improve the construction method of the mouse model with humanized immune system in laboratory, and provide a more favorable drug development tool for tumor immunotherapy.

Key words: NCG mice, humanized immune system, Hu-PBL model, preclinical animal model

中图分类号: